Medistim — Director's Dealing 2023

Oct 27, 2023

Medistim ASA - Disclosure of large shareholding and transactions by close associates

Medistim ASA - Disclosure of large shareholding and transactions by close associates

1,900,219 shares in Medistim ASA were today, 27 September 2023, resolved to be transferred from Aeternum Capital AS to Acapital MEDI HoldCo AS ("HoldCo") by way of a capital contribution in-kind. Aeternum Capital AS is managed by Aeternum Management AS. HoldCo is a 100% owned subsidiary of Aeternum Capital AS. Consequently, no change of beneficial ownership to the shares in Medistim ASA occurs as a result of the transfer, only the direct holder of the shares.

Following the transfer, HoldCo holds 1,900,219 shares in Medistim ASA, equal to approx. 10.36% of the votes and share capital. Aeternum Capital AS holds no shares in Medistim ASA directly following the transfer. No other rights to shares in Medistim ASA are held by any of the above mentioned entities.

Both Aeternum Capital AS and HoldCo are closely associated persons of Anthea Arff-Pettersen, board member and primary insider in Medistim ASA. Please see attached forms for further details.

This information is subject to the disclosure requirements pursuant to Article 19 of the EU Market Abuse Regulation and Sections 4-2, cf. 5-12 of the Norwegian Securities Trading Act.